JP2002522446A5 - - Google Patents

Download PDF

Info

Publication number
JP2002522446A5
JP2002522446A5 JP2000563674A JP2000563674A JP2002522446A5 JP 2002522446 A5 JP2002522446 A5 JP 2002522446A5 JP 2000563674 A JP2000563674 A JP 2000563674A JP 2000563674 A JP2000563674 A JP 2000563674A JP 2002522446 A5 JP2002522446 A5 JP 2002522446A5
Authority
JP
Japan
Prior art keywords
group
compound
hydrogen
protecting
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000563674A
Other languages
English (en)
Japanese (ja)
Other versions
JP4623828B2 (ja
JP2002522446A (ja
Filing date
Publication date
Priority claimed from US09/130,373 external-priority patent/US6335432B1/en
Application filed filed Critical
Publication of JP2002522446A publication Critical patent/JP2002522446A/ja
Publication of JP2002522446A5 publication Critical patent/JP2002522446A5/ja
Application granted granted Critical
Publication of JP4623828B2 publication Critical patent/JP4623828B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000563674A 1998-08-07 1999-08-04 アミン塩基及びヌクレオシドの構造的類似体 Expired - Lifetime JP4623828B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/130,373 US6335432B1 (en) 1998-08-07 1998-08-07 Structural analogs of amine bases and nucleosides
US09/130,373 1998-08-07
PCT/US1999/017587 WO2000008041A1 (en) 1998-08-07 1999-08-04 Structural analogs of amine bases and nucleosides

Publications (3)

Publication Number Publication Date
JP2002522446A JP2002522446A (ja) 2002-07-23
JP2002522446A5 true JP2002522446A5 (cg-RX-API-DMAC10.html) 2006-07-20
JP4623828B2 JP4623828B2 (ja) 2011-02-02

Family

ID=22444397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000563674A Expired - Lifetime JP4623828B2 (ja) 1998-08-07 1999-08-04 アミン塩基及びヌクレオシドの構造的類似体

Country Status (6)

Country Link
US (1) US6335432B1 (cg-RX-API-DMAC10.html)
EP (1) EP1102782B1 (cg-RX-API-DMAC10.html)
JP (1) JP4623828B2 (cg-RX-API-DMAC10.html)
CA (1) CA2339967C (cg-RX-API-DMAC10.html)
DE (1) DE69930647T2 (cg-RX-API-DMAC10.html)
WO (1) WO2000008041A1 (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119470A1 (en) * 1996-06-06 2005-06-02 Muthiah Manoharan Conjugated oligomeric compounds and their use in gene modulation
US20040203024A1 (en) * 1996-06-06 2004-10-14 Baker Brenda F. Modified oligonucleotides for use in RNA interference
US7812149B2 (en) * 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US20050053976A1 (en) * 1996-06-06 2005-03-10 Baker Brenda F. Chimeric oligomeric compounds and their use in gene modulation
US20040171031A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20080119427A1 (en) * 1996-06-06 2008-05-22 Isis Pharmaceuticals, Inc. Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
US20040147022A1 (en) * 1996-06-06 2004-07-29 Baker Brenda F. 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
DE19935302A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen
US8604183B2 (en) * 2002-11-05 2013-12-10 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
WO2005044976A2 (en) * 2003-06-20 2005-05-19 Isis Pharmaceuticals, Inc. Oligomeric compounds for use in gene modulation
US8569474B2 (en) * 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) * 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) * 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US20100280098A1 (en) * 2007-10-05 2010-11-04 Juliano Rudolph L Receptor targeted oligonucleotides
US9778188B2 (en) 2009-03-11 2017-10-03 Industrial Technology Research Institute Apparatus and method for detection and discrimination molecular object
US9482615B2 (en) 2010-03-15 2016-11-01 Industrial Technology Research Institute Single-molecule detection system and methods
US9670243B2 (en) 2010-06-02 2017-06-06 Industrial Technology Research Institute Compositions and methods for sequencing nucleic acids
US8865078B2 (en) 2010-06-11 2014-10-21 Industrial Technology Research Institute Apparatus for single-molecule detection
WO2012044992A2 (en) 2010-09-30 2012-04-05 Agency For Science, Technology And Research (A*Star) Methods and reagents for detection and treatment of esophageal metaplasia
CA2889044A1 (en) 2012-11-15 2014-05-22 Roche Innovation Center Copenhagen A/S Anti apob antisense conjugate compounds
CA2893801A1 (en) 2013-01-30 2014-08-07 F. Hoffmann-La Roche Ag Lna oligonucleotide carbohydrate conjugates
WO2014118272A1 (en) 2013-01-30 2014-08-07 Santaris Pharma A/S Antimir-122 oligonucleotide carbohydrate conjugates
MX367083B (es) 2013-06-27 2019-08-05 Roche Innovation Ct Copenhagen As Oligomeros antisentido y conjugados con diana en la proteina-convertasa subtilisina/kexina tipo 9(pcsk9).
JP6226318B2 (ja) * 2013-09-02 2017-11-08 株式会社 資生堂 光学分割用化合物、光学分割用試薬、光学分割する方法及び光学異性体
GB201408623D0 (en) 2014-05-15 2014-07-02 Santaris Pharma As Oligomers and oligomer conjugates
CA3013683C (en) 2016-03-14 2021-07-13 F. Hoffmann-La Roche Ag Oligonucleotides for reduction of pd-l1 expression
CR20230308A (es) 2020-12-11 2023-09-08 Civi Biopharma Inc Entrega oral de conjugados antisentido que tienen por blanco a pcsk9

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219824A (en) * 1981-04-17 1987-03-31 David C. Ward Modified nucleotides and methods of preparing and using same
EP0235301B1 (en) * 1985-09-09 1992-07-22 Teijin Limited Pyridopyrimidine nucleotide derivatives
JPH07165786A (ja) * 1993-12-10 1995-06-27 Hiroaki Sawai ５位置換ウリジン類、その製造方法及びその用途
CA2274587A1 (en) * 1996-12-10 1998-06-18 Genetrace Systems Inc. Releasable nonvolatile mass-label molecules

Similar Documents

Publication Publication Date Title
CA2339967A1 (en) Structural analogs of amine bases and nucleosides
CN114929236B (zh) 抗病毒前药及其制剂
ES2392840T3 (es) Análogos de nucleótido para el tratamiento de infecciones virales
US8519170B2 (en) Compounds for preparing immunological adjuvant
SK145298A3 (en) Antivirally active heterocyclic azahexane derivatives, process for their preparation, pharmaceutical composition containing same and their use
PL169969B1 (pl) Sposób wytwarzania nowych pochodnych kwasu 5-amino-4-hydroksykapronowego PL PL
PL171232B1 (pl) Sposób wytwarzania nowych pochodnych hydrazyny PL PL
CA2492775A1 (en) Polyalkylene glycol acid additives
US7737273B2 (en) Process for acyclic phosphonate nucleotide analogs
US8450469B2 (en) Synthesis of peptide nucleic acids conjugated with amino acids and their application
KR930016438A (ko) 비뉴클레오티드성 그룹을 갖는 3'-유도된 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도
JP2023520201A5 (cg-RX-API-DMAC10.html)
HU229865B1 (en) Acyclic nucleoside derivatives
SU1561826A3 (ru) Способ получени карбоциклических пуриновых нуклеозидов
US6218568B1 (en) Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
WO1997027195A9 (en) Process for preparing purine derivatives
WO1997027195A1 (en) Process for preparing purine derivatives
JP2002510691A5 (cg-RX-API-DMAC10.html)
JP4336820B2 (ja) オリゴヌクレオチドプローブ
US10676498B2 (en) Processes for the preparation of sofosbuvir and intermediates thereof
US5049689A (en) Process for the selective n-acylation of aminohydroxamic acid derivatives and starting materials used therein
WO1997027194A1 (en) Process for preparing purine derivatives
CA2243650C (en) Process for preparing purine derivatives
KR910007919A (ko) 3'-아지도-3'-데옥시티미딘의 합성공정
Krečmerová et al. Preparation of C-5 substituted cidofovir derivatives